Table 5.
Studies analysing HRU and costs associated with CVD in adults with T2DM in Spain (2009–2019)
| First author of article [citation number] (national or regional) | Year for cost calculation | Patients with T2DM (N) | CVD | CHD | AMI | CVA | PAD | HF |
|---|---|---|---|---|---|---|---|---|
| Crespo [26] (National) | 2012 | 544,515 | – | 5587a,b | – | 5319a,b | 6875a,b | – |
| López-de-Andrés [40] (National) | 2006 | 90,835 | – | – | 6228b,c | – | – | – |
| Arrieta [17] (Madrid) | 2012 | 3268 | 2726.50a | – | – | – | – | – |
| Sancho-Mestre [62] (Valencia) | 2012 | 350,015 | 1441a,d | – | – | – | – | – |
| Mata-Cases [43] (Catalonia) | 2011 | 126,811 | 4815c | 5006c | – | 4720c | 5858c | 6866c |
For abbreviations, see footnote Table 1
All costs are expressed in euros
aMean cost per episode per patient
bHospitalization costs
cTotal cost per patient and year
dPharmaceutical costs